AbbVie Inc.
ABBVAbbVie Inc. (ABBV) is a Healthcare company that currently yields 2.42% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $148.57 and the overvaluation threshold at $233.63. AbbVie Inc. holds a quality score of 45/100 (Average), reflecting 54 consecutive years of dividend growth with a 117% payout ratio. The 5-year dividend CAGR stands at 6.8%.
ABBV Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 48.1% downside to reach the Weiss buy zone
Undervaluation starts near $148.57, where the annual dividend would imply roughly 4.66% yield. That is 2.24% above today's yield.
Buy-zone price
$148.57
Target yield
4.66%
Research checklist
What to clear before buying the yield
Updated Nov 21, 2026
Dividend durability
54YLong dividend history supports a deeper look.
Earnings payout
117%Coverage deserves a closer look in filings.
Cash payout
69%Free cash flow coverage supports the payment.
Dividend growth
6.8%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-11-20 → 2026-11-21
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
AbbVie Inc. is trading near its historical overvaluation band.
Current yield 2.4% vs historical max 6.6% (37% of maximum).
12 consecutive years without a dividend cut.
Elevated payout ratio of 117%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 45/100 quality score says the headline yield needs extra skepticism.
The earnings payout ratio is above 100%, so coverage is the first risk to unpack.
ABBV Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$258
Year 10 Income
$631
Yield on Cost
6.61%
Total Income
$4,150
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what ABBV dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗ABBV Dividend Quality Score
Quality Score
Average
Key Metrics
Invest in ABBV
Check AbbVie Inc. availability and current costs on eToro
Check eToro terms and availability →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ ABBV Dividend Analysis ArticleRelated Reading
Collections